3rd Call for applications
i4i Funding Streams 3a (FPD3a) and 3b (FPD3b)
The NIHR’s Invention for Innovation (i4i) programme would like to invite submissions of applications to funding streams 3a and 3b (FPD3a and FPD3b).
Stream 3a applications must include collaboration between at least one industry and one research (academic or clinical) partner aiming to determine the commercial viability of a proposed device or technology, with the development of a robust route to market and a strong, appropriate consortia serving as key deliverables. Primarily expected to be the first stage of a full collaborative applied research project, total project costs can be no more than £100K in total, of which 75% funding is available.
Stream 3b applications should build on the results of a completed assessment of feasibility and must also have collaboration between at least one industry and one research partner (academic or clinical). This will provide further evidence of the capability to deliver improved healthcare outcomes and commercial opportunity, delivering an advanced prototype along with plans for commercial and intellectual property exploitation. Lasting no longer than 3 years, successful projects will be funded to a maximum of 50% of the total project costs, with £100K-£300K per year in funding available.
All applications must show innovation and must have relevance, impact and potential to contribute to future health gain for patients and the general population. This programme is open to research providers in the academic, NHS communities and industry across the UK.
For further information on eligibility and to submit an application please visit http://www.nihr-ccf.org.uk/site/programmes/i4i/ or email any questions that you may have to i4i.enquiries@quotec.co.uk.
Applications must be submitted via the NIHR CCF website no later than 5.00pm on Friday 29th January 2010. Applicants will be notified of the outcome of their application by late March 2010.
If you would like more detail in this area please get in touch with Damien Bové damien.bove@idaconsultants.com
Damien Bové works as a drug development consultant (pharmaceutical or biotechnology) and regulatory consultant, we work with our clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.
Free Regulatory Watch Service
As you know this website is a great resource for keeping up to date with developments and regulations, why not get our FREE monthly regulatory and market round up. You can un-subscribe at any time and we do not share your details with anybody.
This guideline ap
recombinant vaccines for the prevention and treatment of infectious disease, and provides guidance on quality, non-clinical and clinical aspects.
Turn your Business Into an Investor Magnet
How to Write a Business Plan – Free E-Course
Get the secrets that turns your project into an investment magnet, 100% of our clients raise the finance they need to take their projects to the next stage, we will share these secrets with you. – Sign up for Free
“Please note that the pages on this website are designed to provide you with general information only. We make no warranties, representations or undertakings about any of its content. This includes the completeness, accuracy and fitness for any particular purpose, or the content of any third party site referred to or accessed through it. You are personally responsible for ensuring that the information is correct and we will not be held liable or accountable for any mistakes that occur.”
